Registered Kenya · PPB

SIMCLOX 500MG

AMPILICILLIN TRIHYDRATE BP & CLOXACILLIN SODIUM BP

H2019/CTD4599/765ER AMPILICILLIN 250MG & CLOXACILLIN 250MG GENERIC/BIOSIMILARS antiinfectives for systemic use INN generic

What it does

Ampicillin is an antibiotic that helps treat bacterial infections.

Commonly used for: bacterial infections, ear infections (otitis media), lung infections (pneumonia), urinary tract infections (UTIs) …

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
H2019/CTD4599/765ER
Registration date
2019-02-21 00:00:00
Expiry date
-
Status
Registered
Active ingredient
AMPILICILLIN TRIHYDRATE BP & CLOXACILLIN SODIUM BP
Strength
-
Pack size
10 X 10'S BLISTER
Therapeutic class
GENERIC/BIOSIMILARS
ATC class (WHO)
J01CF - Beta-lactamase resistant penicillins
RxNorm RxCUI
2625
Manufacturer / MAH
Universal Corporation
Applicant / LTR
STRIDES SHASUN LIMITED
Country of origin
FOREIGN
Manufacturer location
QM56+MH6, Rungiri, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 19:45:06 · updated 2026-08-03 02:54:09

Drug Interactions

6
Check interactions

Severe (1)

Penicillins - increases risk of adverse effects

Valproate increases the risk of adverse effects when given with penicillins (pivmecillinam). Avoid.

Severe Anecdotal

Unknown (5)

Penicillins - increases risk of skin rash

Allopurinol increases the risk of skin rash when given with penicillins (amoxicillin, ampicillin).

Unknown Study

Penicillins - increases exposure

Leflunomide is predicted to increase the exposure to penicillins (benzylpenicillin).

Unknown Theoretical

Penicillins - increases exposure

Nitisinone is predicted to increase the exposure to penicillins (benzylpenicillin).

Unknown Study

Penicillins - increases exposure

Teriflunomide is predicted to increase the exposure to penicillins (benzylpenicillin).

Unknown Study

Phenindione - increases risk of bleeding events

Penicillins are predicted to increase the risk of bleeding events when given with phenindione.

Unknown Theoretical

Data from BNF 85 (British National Formulary). This is not a substitute for professional medical advice. Matched via: class

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About ampilicillin

Ampicillin is an antibiotic that helps treat bacterial infections.

What it treats

  • bacterial infections
  • ear infections (otitis media)
  • lung infections (pneumonia)
  • urinary tract infections (UTIs)
  • meningitis

How it works

Ampicillin works by killing bacteria or stopping their growth, helping the body fight off infections.

Who it's for

It is for people who have certain bacterial infections as prescribed by a healthcare professional.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About cloxacillin

Cloxacillin is an antibiotic that helps fight bacterial infections.

What it treats

  • bacterial infections
  • skin infections
  • bone infections
  • respiratory tract infections

How it works

Cloxacillin works by killing bacteria or preventing their growth.

Who it's for

Cloxacillin is for people who have specific bacterial infections that need treatment.

Drug class

Penicillins

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: ampilicillin

Ampicillin is a broad-spectrum penicillin antibiotic used to treat a variety of bacterial infections. It is effective against both Gram-positive and some Gram-negative bacteria. Ampicillin is commonly employed in the management of respiratory tract infections, urinary tract infections, meningitis, and gastrointestinal infections. It is available in oral and parenteral formulations.

Indications

  • Bacterial pneumonia
  • Urinary tract infections
  • Meningitis
  • Gastroenteritis
  • Sepsis
  • Endocarditis prophylaxis
  • Skin and soft tissue infections

Dosage

Children: Refer to the BNF for Children for specific dosing information. Pediatric dosing typically depends on the child's weight and the type of infection being treated.

Adults: Refer to the BNF for specific dosing guidelines based on the infection type and severity. Generally, doses range from 250 mg to 500 mg every 6 hours, depending on the clinical condition.

Mechanism of action

Ampicillin works by inhibiting bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs), which are essential for cell wall integrity. This binding inhibits the transpeptidation enzyme, leading to cell lysis and death, particularly in actively growing bacteria.

Pharmacodynamics

The pharmacodynamics of ampicillin involve its time-dependent bactericidal activity against susceptible bacteria. The effectiveness of ampicillin is determined by the time the drug concentration remains above the minimum inhibitory concentration (MIC) for the target organisms. Resistance can occur through the production of beta-lactamases, which hydrolyze the beta-lactam ring of the antibiotic.

Pharmacokinetics

Ampicillin is absorbed from the gastrointestinal tract when administered orally, although its bioavailability is about 40-60%. It is widely distributed in body fluids and tissues and can penetrate the blood-brain barrier, especially during meningitis. The drug is primarily excreted unchanged in the urine, and its half-life ranges from 1 to 2 hours in healthy adults. Renal impairment can significantly prolong its half-life.

Contra-indications

  • Hypersensitivity to penicillins or any components of the formulation
  • History of jaundice or hepatic dysfunction associated with ampicillin use

Adverse effects

  • Nausea
  • Vomiting
  • Diarrhea
  • Rash
  • Allergic reactions including anaphylaxis
  • Hepatic enzyme elevation
  • Superinfection with non-susceptible organisms

Interactions

  • Allopurinol may increase the incidence of rash
  • Probenecid can decrease renal clearance of ampicillin, leading to increased plasma concentrations
  • Combined use with methotrexate may increase the toxicity of methotrexate

Precautions

  • Use with caution in patients with renal impairment
  • Monitor for signs of anaphylaxis after administration
  • Consider alternative therapy in patients with a history of severe allergic reactions to beta-lactam antibiotics

Pregnancy

Ampicillin is classified as category B; it is generally considered safe for use during pregnancy, although caution is advised and it should be used only if clearly needed.

Breast-feeding

Ampicillin is excreted in breast milk; use with caution as it may affect the nursing infant.

Storage

Store at room temperature, away from moisture and heat. Reconstituted solutions should be refrigerated and used within a specified time frame.

Formulations

  • Capsules
  • Tablets
  • Oral suspension
  • Intravenous injection
  • Intramuscular injection

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: cloxacillin

BNF-referenced

Cloxacillin is a semisynthetic antibiotic belonging to the penicillin class. It is primarily used for its bactericidal properties against certain Gram-positive bacteria, particularly those that produce beta-lactamase. Cloxacillin is effective in treating infections caused by staphylococci and is characterized by its ability to resist degradation by beta-lactamase enzymes, making it a valuable option in penicillin-resistant bacterial infections.

Indications

  • Skin and soft tissue infections caused by susceptible Staphylococcus species
  • Bone and joint infections (e.g., osteomyelitis) due to Staphylococcus
  • Endocarditis prophylaxis in patients with penicillin-sensitive organisms
  • Respiratory tract infections caused by susceptible organisms

Dosage

Children: For children, the dosage of cl

Adults: The usual adult dose for cloxacillin is 250 mg to 500 mg every 6 hours, depending on the severity and type of infection. Higher doses may be required for more severe infections.

Mechanism of action

Cloxacillin exerts its antibacterial effects by binding to specific penicillin-binding proteins (PBPs) located within the bacterial cell wall. This binding inhibits the third and final stage of bacterial cell wall synthesis, leading to cell lysis mediated by bacterial autolytic enzymes such as autolysins. Cloxacillin is particularly effective against strains that produce penicillinase, thus broadening its spectrum of activity compared to penicillin.

Pharmacodynamics

As a semisynthetic penicillin, cloxacillin exhibits bactericidal activity, primarily targeting Gram-positive bacteria. Its action is contingent upon the bacteria being in a multiplying state since penicillins do not affect existing cell walls. Cloxacillin's effectiveness is enhanced against beta-lactamase producing strains, allowing for successful treatment of infections that would otherwise be resistant to standard penicillin.

Pharmacokinetics

Cloxacillin is well absorbed from the gastrointestinal tract, with peak plasma concentrations occurring approximately 1 to 2 hours after oral administration. It has a volume of distribution that indicates good tissue penetration, and it is metabolized in the liver. The elimination half-life is approximately 0.5 to 1 hour, with renal excretion being the primary route of elimination for the unchanged drug.

Contra-indications

  • History of hypersensitivity to cloxacillin or any other penicillin antibiotics
  • Severe renal impairment
  • History of allergic reactions to beta-lactam antibiotics

Adverse effects

  • Allergic reactions (rash, urticaria, anaphylaxis)
  • Gastrointestinal disturbances (nausea, vomiting, diarrhea)
  • Hepatic dysfunction (elevated liver enzymes)
  • Renal impairment (nephrotoxicity)
  • Hematological reactions (eosinophilia, thrombocytopenia)

Interactions

  • Probenecid may increase serum levels of cloxacillin
  • Anticoagulants (may increase effect)
  • Other antibiotics (may have antagonistic effects)

Precautions

  • Use with caution in patients with renal impairment
  • Monitor for signs of allergic reactions
  • Caution in patients with a history of gastrointestinal disease, particularly colitis

Pregnancy

Cloxacillin is generally considered safe to use during pregnancy, but it should only be used when clearly needed.

Breast-feeding

Cloxacillin is excreted in breast milk; caution is advised when administering to nursing mothers.

Storage

Store in a cool, dry place away from light. Once reconstituted, it should be stored in the refrigerator and used within a specified time frame as per manufacturer instructions.

Formulations

  • Capsules
  • Injection (vial for intravenous use)
  • Oral suspension

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: cloxacillin

PubChem CID 6098

Molecular formula: C19H18ClN3O5S

Mechanism of action

By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, cloxacillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cloxacillin interferes with an autolysin inhibitor. ...ITS ANTIBACTERIAL SPECTRUM AGAINST GRAM-POSITIVE BACTERIA IS LIKE THAT OF PENICILLIN EXCEPT IT IS BROADER BY MARGIN OF THOSE STRAINS OR SPECIES THAT PRODUCE PENICILLINASE. ...IT IS LESS ACTIVE THAN PENICILLIN G AGAINST NON-PENICILLINASE-PRODUCING BACTERIA, ESPECIALLY STREPTOCOCCI. /CLOXACILLIN MONOHYDRATE/ SINCE PENICILLIN HAS NO EFFECT ON EXISTING CELL WALLS, BACTERIA MUST BE MULTIPLYING FOR BACTERIAL ACTION OF PENICILLIN TO BE MANIFEST. /PENICILLINS/ The penicillins and their metabolites are potent immunogens because of their ability to combine with proteins and act as haptens for acute antibody-mediated reactions. The most frequent (about 95 percent) or "major" determinant of penicillin allergy is the penicilloyl determinant produced by opening the beta-lactam ring of the penicillin. This allows linkage of the penicillin to protein at the amide group. "Minor" determinants (less frequent) are the other metabolites formed, including native penicillin and penicilloic acids. /Penicillins/ Bactericidal; inhibit bacterial cell wall synthesis. Action is dependent on the ability of penicillins to reach and bind penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. Penicillin-binding proteins (which include transpeptidases, carboxypeptidases, and endopeptidases) are enzymes that are involved in the terminal stages of assembling the bacterial cell wall and in reshaping the cell wall during growth and division. Penicillins bind to, and inactivate, penicillin-binding proteins, resulting in the weakening of the bacterial cell wall and lysis. /Penicillins/ TOLERANCE DEVELOPED TO MULTIPLE DOSING. /PENICILLINS/

Pharmacodynamics

Cloxacillin is a semisynthetic antibiotic in the same class as penicillin. Cloxacillin is for use against staphylococci that produce beta-lactamase.

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.